CD83 and ovarian carcinoma: Finally, we found that ovarian cancer patients’ survival inversely correlated with the level of CD83 expression in 907 ovarian cancer patients (low CD83 expression: 652, the high expression: 255), as patients with high CD83 expression lived significantly shorter compared with their counterparts with low CD83 expression (Figure 1d).